• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form DEFA14A filed by Edgewell Personal Care Company

    1/24/25 4:56:05 PM ET
    $EPC
    Package Goods/Cosmetics
    Consumer Discretionary
    Get the next $EPC alert in real time by email
    DEFA14A 1 proxysupplement1232025fina.htm DEFA14A Document
    =
     
     
     
    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
     
    SCHEDULE 14A
     
    Proxy Statement Pursuant to Section 14(a) of
    the Securities Exchange Act of 1934 (Amendment No.)
     
    Filed by the Registrant   x
     
    Filed by a Party other than the Registrant   ¨
     
    Check the appropriate box:
     
    ¨ 
    Preliminary Proxy Statement
     
     
    ¨
    Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
     
     
    ¨ 
    Definitive Proxy Statement
     
     
    x
    Definitive Additional Materials
     
     
    ¨
    Soliciting Material under §240.14a-12
     
    image_0.jpg
     
    EDGEWELL PERSONAL CARE COMPANY

    (Name of Registrant as Specified in Its Charter)
     
    (Name of Person(s) Filing Proxy Statement, if other than the Registrant)
     
    Payment of Filing Fee (Check the appropriate box):
     
    x 
    No fee required.
     
     
    ¨
    Fee paid previously with preliminary materials.
     
     
    ¨
    Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a6(i)(1) and 0-11.
     

     
     

     


    =
     
    image_1.jpg

    EDGEWELL PERSONAL CARE COMPANY
    6 Research Drive
    Shelton, Connecticut 06484

    SUPPLEMENT TO PROXY STATEMENT
    FOR THE 2025 ANNUAL MEETING OF SHAREHOLDERS


    This proxy statement supplement (this “Supplement”), dated January 24, 2025, supplements the definitive proxy statement filed with the Securities and Exchange Commission (the “SEC”) by Edgewell Personal Care Company, a Missouri corporation (the “Company”), on December 19, 2024 (the “Proxy Statement”) and made available to the Company’s stockholders in connection with the solicitation of proxies by the Company’s Board of Directors for the 2025 Annual Meeting of Shareholders to be held at 8:30 a.m. Eastern Time on Thursday, February 6, 2025 at the Renaissance Daytona Beach Oceanfront Hotel, 640 North Atlantic Avenue, Daytona Beach, Florida (the “Annual Meeting”).

    This Supplement is being filed with the SEC on January 24, 2025. Only stockholders of record as of the close of business on November 29, 2024 are entitled to notice of, and to vote at, the Annual Meeting.

    The purpose of this Supplement is to amend certain disclosures in the “Executive Compensation,” “Pay Versus Performance” and “Stock Ownership Information” sections of the Proxy Statement to include information as to compensation and beneficial ownership of Paul R. Hibbert, the Chief Supply Chain Officer of the Company, as a “named executive officer” and to clarify certain disclosures in the “Executive Compensation” section of the Proxy Statement relating to the Company’s insider trading policy and the timing and procedures for grants of equity awards. The “Executive Compensation” section of the Proxy Statement, as revised by this Supplement, should be read in connection with the Company’s non-binding advisory vote on executive compensation.

    Except as revised by the information contained herein, this Supplement does not otherwise revise or update any other disclosures presented in the Proxy Statement. This Supplement should be read with the Proxy Statement, and, from and after the date of this Supplement, any references to the “Proxy Statement” shall be deemed to include the Proxy Statement as amended by this Supplement.

    IF YOU HAVE ALREADY VOTED BY INTERNET, TELEPHONE, OR BY MAIL, YOU DO NOT NEED TO TAKE ANY ACTION UNLESS YOU WISH TO CHANGE YOUR VOTE. Proxy voting instructions already returned by stockholders (via Internet, telephone, or mail) will remain valid and will be voted at the Annual Meeting unless revoked. Important information regarding how to vote your shares and revoke or change your vote already cast is available in the Proxy Statement under the captions “How You Can Vote” and “How You May Revoke or Change your Vote.”



    =
    EXECUTIVE COMPENSATION DISCUSSION AND ANALYSIS
    (updates)
    Composition of our NEOs in Fiscal 2024
    The following narratives and tables discuss the compensation paid in fiscal 2024 to our CEO, CFO, our other three most highly compensated executive officers who served as of September 30, 2024, and an additional executive officer who served during fiscal 2024, whom we refer to collectively as our “named executive officers.” This year’s NEOs are shown below:

    NEO
    Role
    Rod R. Little
    President and Chief Executive Officer since March 2019
    Daniel J. Sullivan (1)
    Chief Operating Officer and Chief Financial Officer since August 2024
    Eric F. O’Toole (2)
    Former President, North America
    LaTanya Langley (3)
    Chief People Officer, Chief Legal Officer and Secretary since November 2023
    John N. Hill (4)
    Former Chief Human Resources Officer


    Paul R. Hibbert



    Chief Supply Chain Officer since June 2020



    (1) Mr. Sullivan has served as Chief Financial Officer since April 2019. Mr. Sullivan has served as Chief Operating Officer and Chief Financial Officer from August 6, 2024 until December 1, 2024, at which time he assumed the role of Chief Operating Officer only.
    (2) Mr. O’Toole left the Company effective November 15, 2024.
    (3) Ms. Langley has served as our Chief Legal Officer since February 2022. Ms. Langley has served as our Chief People Officer, Chief Legal Officer and Secretary since November 2023.
    (4) Mr. Hill retired from the Company effective January 5, 2024.
    Summary of Key Elements of Executive Compensation in Fiscal 2024
    The HC&CC evaluated the annual base salaries of the individuals then serving as executive officers at its November 2023 meeting and set the base salaries of the following NEOs:

    Name
    Fiscal 2023
    ($)
    Effective
    November 1, 2023
    ($)
    Increase
    ($ / %)
    Mr. Little
    $
    1,100,000
    $
    1,100,000
    $0
    Mr. Sullivan
    $
    750,000
    $
    800,000
    $50,000 (6.7%)
    Mr. O’Toole
    $
    600,000
    $
    650,000
    $50,000 (8.3%)
    Ms. Langley
    $
    460,000
    $
    500,000
    $40,000 (8.7%)
    Mr. Hill
    $
    465,000
    $
    478,950
    $13,950 (3.0%)


    Mr. Hibbert


    $
    465,000


    $
    483,600



       
      $18,600 (4.0%)


    The performance goals for each metric were set by the HC&CC at the beginning of fiscal 2024. The HC&CC assigned individual bonus targets to each of the executive officers, based upon individual performance and peer group market data provided by Meridian. The following bonus targets, defined as a percentage of the individual’s base salary for the term of the bonus program, were assigned to the following individuals at the HC&CC’s November 2023 meeting:

    Name
    Bonus Target as
    a Percentage of
    Base Salary
    Mr. Little
    125%
    Mr. Sullivan
    75%
    Mr. O’Toole
    75%
    Ms. Langley
    70%
    Mr. Hill
    65%


    Mr. Hibbert





    70%






    =
    In keeping with the Company’s policy of pay-for-performance, the following table sets forth the bonus target percentages approved for each NEO for the prior three years along with the potential bonus amount and the actual bonus paid.

    Name and Principal Position
    Year
    Salary
    Bonus Target
    Percentage
    Bonus Available
    at Target
    Bonus Paid
    Rod R. Little
    President and Chief Executive Officer
    2024
    $
    1,100,000
    125%
    $
    1,375,000
    $
    1,338,563
    2023
    $
    1,100,000
    125%
    $
    1,375,000
    $
    1,727,770
    2022
    $
    1,050,000
    115%
    $
    1,207,500
    $
    1,017,923
    Daniel J. Sullivan
    Chief Financial Officer and
    Chief Operating Officer
    2024
    $
    800,000
    75%
    $
    600,000
    $
    584,100
    2023
    $
    750,000
    75%
    $
    562,500
    $
    706,680
    2022
    $
    730,000
    75%
    $
    547,500
    $
    424,619
    Eric F. O’Toole
    Former President, North America
    2024
    $
    650,000
    75%
    $
    487,500
    $
    474,582
    2023
    $
    600,000
    75%
    $
    450,000
    $
    565,344
    2022
    $
    520,000
    70%
    $
    364,000
    $
    282,304
    LaTanya Langley
    Chief People Officer, Chief Legal Officer and Secretary
    2024
    $
    500,000
    70%
    $
    325,000
    $
    340,725
    John N. Hill
    Former Chief Human Resources Officer
    2024
    $
    478,950
    65%
    $
    311,317
    0  (1)
    2023
    $
    465,000
    65%
    $
    302,250
    $
    379,723
    2022
    $
    445,000
    60%
    $
    267,000
    $
    207,075

    Paul R. Hibbert
    Chief Supply Chain Officer



    2024





    $
     483,600






    70%





    $
    338,520





    $
       329,549






    2023





    $
    465,000






    65%





    $
    302,250





    $
    379,723






    2022





    $
    445,000






    60%





    $
    267,000





    $
    207,075



    (1)   Mr. Hill retired on January 5, 2024. As a result, no bonus was paid.

    Timing and Procedures for Grants

    Other than in exceptional cases, such as promotions or new hires, long-term incentive awards are generally granted in the first quarter of the fiscal year (October through December), at the time when salary levels and short-term incentive programs for the new fiscal year are determined. The HC&CC does not take material nonpublic information into account when determining the timing and terms of equity awards. The Company does not time the disclosure of material nonpublic information for the purpose of affecting the value of executive compensation.

    Our CEO recommends to the HC&CC the number and type of RSEs and stock options to be awarded to each NEO (other than our CEO). The HC&CC considers the equity awards for executive officers based in part upon benchmarked data from our peer group provided by Meridian valued on the date of grant, as well as other factors, such as the officers’ individual performance, current dilution rates, and the market run-rate for equity grants among the peer group.

    With respect to awards to our CEO, Meridian, without input from our CEO or other members of management, provides a competitive market analysis to the HC&CC based on the benchmarking peer group. The HC&CC determines the award to recommend to our Board considering the market analysis, performance of our Company, returns to shareholders, and experience and effectiveness of our CEO’s leadership, as well as the input from Meridian.

    The RSE awards are stock settled at the time of vesting when they convert into unrestricted shares of our common stock. PRSE awards are earned based on the level of performance over the vesting period against pre-established goals. Upon vesting, stock option awards become exercisable for the purchase of shares of our common stock at a price per share established at the time of grant, so that the option will have no financial value unless the price of our common stock appreciates following the date of grant. The value of all our equity awards fluctuates based on performance of our Company’s common stock over time. This combination of financial performance and stock price performance enhances alignment with our shareholders.

    Anti-Hedging Policy

    Our insider trading policy governs the purchase, sale, and/or other dispositions of our securities by directors, officers and employees, and is reasonably designed to promote compliance with insider trading laws, rules and regulations, and NYSE standards. Under our insider trading policy, directors, officers and employees or their designees are prohibited from engaging in speculative trading or hedging transactions in Edgewell securities or purchasing any financial instruments or entering into any other arrangements designed to hedge or offset any decrease in the market value of Edgewell securities, including prohibitions on:
    •investing or trading in market-traded options on Edgewell securities — i.e., puts and calls;
    •purchasing financial instruments (including prepaid variable forward contracts, equity swaps, collars, and exchange funds) that are designed to profit from, hedge or offset any change in the market value of equity securities (1) granted by our Company to the director, officer or employee as part of the compensation of the employee or member of our Board; or (2) held, directly or indirectly, by the director, officer or employee;
    •engaging in “short-sales” of Edgewell securities — i.e., selling Edgewell stock not owned at the time of the sale;
    •entering into a “sale against the box” transaction (loaning Edgewell stock to another individual and receiving cash back as security for the loan); or


    =
    •speculating on relatively short-term price movements of Edgewell securities — i.e., engaging in a purchase and sale of Edgewell stock within a short period of time.

        Our policy prohibits directors, officers and employees from purchasing Edgewell securities on margin, holding Edgewell securities in a margin account, or pledging Edgewell securities as collateral. The policy also prohibits engaging in any other transaction involving Edgewell securities that suggests the misuse of information that is unavailable to the general public.


    =
    SUMMARY COMPENSATION TABLE
    This Summary Compensation Table sets forth information for compensation relating to fiscal years 2024, 2023 and 2022. For a discussion of fiscal 2024 compensation, see “Compensation Discussion and Analysis” above.
    Name and
    Principal Position
    YearSalary
    Bonus
    (1)
    Stock
    Awards
    (2)
    Option
    Awards
    (3)
    Non-
    Equity
    Incentive
    Plan
    Compen-
    sation
    (1)
    Change in
    Pension
    Value and
    Non-
    qualified
    Deferred
    Compen-
    sation
    Earnings
    (4)
    All Other
    Compen-
    sation
    (5)
    Total
    Rod R. Little
    President and Chief Executive Officer
    2024$1,100,000$0$6,267,970$1,200,003$1,338,563$0$172,377$10,078,913
    2023$1,095,833$0$6,360,768$1,200,006$1,727,440$0$133,081$10,157,128
    2022$1,045,833$0$6,012,124$1,100,002$1,017,923$0$144,398$ 9,320,280
    Daniel J. Sullivan
    Chief Financial Officer and
    Chief Operating Officer
    2024$ 795,834$0$1,360,174$ 280,007$ 584,100$0$ 20,293$ 3,040,408
    2023$ 748,334$0$1,451,162$ 280,002$ 706,680$0$ 19,785$ 3,205,963
    2022$ 728,333$0$1,279,859$ 240,013$ 424,619$0$ 76,354$ 2,749,178
    Eric F. O’Toole
    Former President, North America
    2024 $ 645,834 $0 $1,068,732 $ 220,007 $ 474,582 $0 $ 71,627 $ 2,480,782
    2023 $ 593,334 $0 $1,036,533 $ 200,006 $ 565,344 $0 $ 50,689 $ 2,445,906
    2022$ 518,333$0$ 799,898$ 150,001$ 282,304$0$ 18,606$ 1,769,142
    LaTanya Langley
    Chief People Officer, Chief Legal Officer and Secretary
    2024 $ 496,667 $0 $ 777,291 $ 160,008 $ 340,725 $0$ 54,126 $ 1,828,817
    John N. Hill
    Former Chief Human Resources Officer
    2024

    2023
    $ 127,646

    $ 463,334
    $0

    $0
    $ 0

    $ 673,777
    $ 0

    $ 130,009
    $ 0

    $ 379,723
    $232,568
    $ 6,262
    $189,648
    $2,147,807
         (6)
    $ 46,929
    $ 2,514,283

    $ 1,896,535
          $13,115  
    2022$ 443,750$0$ 693,252$ 130,014$ 207,075$114,917 $ 57,611$ 1,623,822
          ($22,797)  
    Paul R. Hibbert
    Chief Supply Chain Officer
    2024$ 482,050$0$ 680,087$ 140,003$ 329,549$0$ 58,608$ 1,690,297
    2023$ 463,334 $0 $ 673,777 $ 130,009 $ 379,723 $0 $ 46,064 $ 1,692,907
    2022$ 443,883$0$ 639,984$ 120,007$ 207,075$0$ 50,697$ 1,769,142

    (1) All awards under our Executive Officer Bonus Program are based upon achievement of Company performance measures established at the beginning of a performance period. Consequently, the value of all bonuses earned during the fiscal year under these programs has been included in the Non-Equity Incentive Plan Compensation column of this table. See “Compensation Discussion and Analysis — Elements of Compensation — Incentive Programs — Short-Term Incentive Program — Annual Cash Bonus.”

    (2) The amounts listed in this column include both time-vesting and performance-based restricted stock equivalent grants awarded in fiscal 2024 to our named executive officers. The value of the performance-based award is calculated in accordance with the Financial Accounting Standard Board’s (“FASB”) ASC Section 718. Our Company records estimated expense for performance-based grants based on target achievement of performance metrics for the three-year period, unless evidence exists that achievement above or below target for the applicable performance metric is more likely to occur. The following is the maximum value, if paid, for the performance award granted in fiscal 2024, based on the grant date value: Mr. Little, $7,100,034; Mr. Sullivan, $1,400,009; Mr. O’Toole, $1,100,002; Ms. Langley, $800,029; Mr. Hibbert, $700,004. Mr. Hill did not receive an award due to his planned retirement.



    =
    (3) The amounts listed in this column reflect the aggregate grant date fair value of stock options granted to our named executive officers calculated in accordance with FASB ASC Section 718, and do not reflect actual amounts paid to them, or realized by them, or that may be realized upon exercise by them. Assumptions used in the calculation of these amounts are included in “Note 15. Share-Based Payments” of the Notes to Consolidated Financial Statements of our Annual Report on Form 10-K for the fiscal year ended September 30, 2024.

    (4) The amount reported in this column with respect to fiscal 2024 consists of the following:
    Name
    Change in
    Pension Value (i)
    Above-market
    Earnings on
    Non-Qualified
    Deferred
    Compensation
    Total
    Mr. Little
    $0
    $0
    $0
    Mr. Sullivan
    $0
    $0
    $0
    Mr. O’Toole
    $0
    $0
    $0
    Ms. Langley
    $0
    $0
    $0
    Mr. Hill
    $
    10,542
    $
    222,026
    $
    232,568
    $
    6,262(ii)
    $0
    $
    6,262


    Mr. Hibbert





     $0




    $0




        
    $0



    (i) Unless otherwise noted, these amounts reflect the aggregate changes in the actuarial present value of accumulated benefits under our defined benefit pension plan and the SERP, which are described in the narrative to the “Pension Benefits Table.” For the final average earnings formula benefit under the defined benefit pension plan, this amount reflects the difference in the calculated present value of the benefit during fiscal 2024. To the extent that payments under the defined benefit pension plan exceed limitations imposed by the U.S. Internal Revenue Service, the excess will be paid under the terms of the SERP. This also includes above-market earnings on non-qualified deferred compensation in our deferred compensation plan.

    (ii) This amount reflects Mr. Hill’s participation in the Pension Plan for Employees of Edgewell Personal Care, which was a frozen plan in Canada. The plan was wound up and sold to an annuity insurance company on March 31, 2023. The amount for Mr. Hill was converted from Canadian dollars into U.S. dollars at the exchange rate of 1 CAD equals 0.7395 USD, the exchange rate in effect on September 30, 2024.

    (5) The amounts reported in this column with respect to fiscal 2024 consist of the following:
    Name
    Company
    Matching
    Contributions
    401(k) Plan
    (i)
    Company
    Matching
    Contributions
    ESIP
    (i)
    Term Life
    Insurance
    Premiums
    (ii)
    Executive
    Financial
    Planning
    Program
    (iii)
    HSA
    Employer
    Contribution
    (iv)
    Wellness
    Credit
    (v)
    AD&D
    and LTD
    Insurance
    Premiums
    (vi)
    Total
    Mr. Little
    $
    20,700
    $
    149,846
    $
    102
    $0
    $
    1,500
    $
    25
    $
    204
    $
    172,377
    Mr. Sullivan
    $
    18,487
    $
    0
    $
    102
    $0
    $
    1,500
    $0
    $
    204
    $
    20,293
    Mr. O’Toole
    $
    20,700
    $
    50,621
    $
    102
    $0
    $0
    $0
    $
    204
    $
    71,627
    Ms. Langley
    $
    21,330
    $
    30,738
    $
    102
    $
    1,752
    $0
    $0
    $
    204
    $
    54,126
    Mr. Hill
    $
    6,554
    $
    31,023
    $
    30
    $0
    $0
    $0
    $
    59
    $
       37,666 (6)


    Mr. Hibbert




    $
    20,432





    $
     31,069





    $
    102




    $5,000



    $1,500



    $300




    $
    204




    $
    58,608
    (i) Company matching contributions or accruals in our 401(k) plan and ESIP.

    (ii) Term life insurance premiums paid by our Company for the first $50,000 coverage for each of the NEOs.

    (iii) We reimburse the executives for 80% of the cost of personal financial advisory services, up to certain annual maximums.

    (iv) Our Company pays an annual contribution to a Health Savings Account for each executive who elects to participate.

    (v) Our Company pays an annual wellness credit for each executive who completes a biometric screening and health survey.

    (vi) Our Company pays the premiums for Group Accidental Death & Dismemberment ($12.00 per person) and Group Long-Term Disability ($192 per person).

    (6) As a result of his retirement, the amount reported in this column reflects the additional compensation Mr. Hill received of $1,319,442 severance; $362,605 deferred compensation pay; $155,040 SERP payout; and $273,055 EPC defined benefit plan payout.
    The above list of perquisites does not include any contributions made by our charitable trust which may have been made at the request of any of the NEOs. The trustees of that trust, who are employees of our Company, review requests for contributions to charitable organizations from employees, officers, directors, and the community at large, and, in their sole discretion, authorize contributions in accordance with the purposes of the trust. Officers are also eligible to participate in the charitable trust matching gift program, which is generally available to U.S. employees. Under this program, the foundation matches 100% of charitable donations of a minimum of $25 made to eligible charities, up to a maximum of $5,000 per year for each individual. Our Company will continue to honor requests under the charitable trust guidelines as long as funds exist at an appropriate level to do so.
     



    =
    GRANTS OF PLAN-BASED AWARDS
    Awards to the NEOs, and to other key executives, were made in fiscal 2024 under two separate plans or programs:
    • Our short-term incentive program, pursuant to which potential cash awards were granted, dependent upon achievement of Company performance measures established at the beginning of the term of the program, as described in more detail in “Compensation Discussion and Analysis — Elements of Compensation — Incentive Programs — Short-Term Incentive Program — Annual Cash Bonus,” an
    • Our long-term incentive program, pursuant to which RSE awards (performance-based and time-vesting) and stock option awards were granted under the terms of our 2nd A&R 2018 Plan as described in more detail in “Compensation Discussion and Analysis — Elements of Compensation — Long-Term Incentive Programs — Equity Awards (Restricted Stock Equivalents and Options).”

    GRANTS OF PLAN-BASED AWARDS TABLE

    NameType of Award
    Meeting
    Date
    Grant
    Date
    Estimated Future Payouts
    Under Non-Equity
    Incentive Plan Awards
    Estimated Future Payouts
    Under Equity
    Incentive Plan Awards (#)
    All Other
    Stock
    Awards:
    Number of
    Shares of
    Stock (#)
    All Other
    Option
    Awards:
    Number of
    Shares
    Underlying
    Options (#)
    Exercise
    or Base
    Price of
    Option
    Awards
    ($/Sh)
    Grant
    Date
    Fair
    Value Of
    Stock
    And Option
    Awards (1)
    ThresholdTargetMaximumThresholdTargetMaximum
    Mr. LittleBonus: Annl. Perf. (2)   $687,500$1,375,000$2,750,000       
    Perf Awd: RSE (3)11/1/202311/10/2023         43,835  $1,500,034
    Perf Awd: PRSE (4)11/1/202311/10/2023     51,871 103,741 207,482   $4,767,936
    Perf Awd: Options (5)11/1/202311/10/2023          89,021  $34.22$1,200,003
    Mr. SullivanBonus: Annl. Perf. (2)   $300,000$ 600,000$1,200,000       
    Perf.Awd: RSE (3)11/1/202311/10/2023         12,274  $ 420,016
    Perf.Awd: PRSE (4)11/1/202311/10/2023     10,228   20,456   40,912   $ 940,158
    Perf.Awd: Options (5)11/1/202311/10/2023          20,772  $34.22$ 280,007
    Mr. O’TooleBonus: Annl. Perf. (2)   $243,750$ 487,500$ 975,000       
    Perf Awd: RSE (3)11/1/202311/10/2023          9,644  $ 330,018
    Perf Awd: PRSE (4)11/1/202311/10/2023       8,037   16,073   32,146   $ 738,715
    Perf Awd: Options (5)11/1/202311/10/2023          16,321  $34.22$ 220,007
    Ms. LangleyBonus: Annl. Perf. (2)   $175,000$ 350,000$ 700,000      
    Perf Awd: RSE (3)11/1/202311/10/2023       7,014$ 240,019
    Perf Awd: PRSE (4)11/1/202311/10/2023       5,845   11,690   23,380$ 537,272
    Perf Awd: Options (5)11/1/202311/10/2023       11,870   $34.22$ 160,008
    Mr. HillBonus: Annl. Perf. (2)   $155,659$ 311,318$ 622,635       
    Perf Awd: RSE (3)11/1/202311/10/2023        $ 0
    Perf Awd: PRSE (4)11/1/202311/10/2023      $ 0
    Perf Awd: Options (5)11/1/202311/10/2023       $ 0
    Mr. HibbertBonus: Annl. Perf. (2) $169,260$ 338,520$ 677,040
    Perf Awd: RSE (3)11/1/202311/10/2023   6,137$ 210,008
    Perf Awd: PRSE (4)11/1/202311/10/2023    5,114   10,228   20,456$ 470,079
    Perf Awd: Options (5)11/1/202311/10/2023   10,386$34.22$ 140,003

    (1) This represents the grant date fair value calculated in accordance with FASB ASC Section 718, excluding forfeiture assumptions. For time-vesting awards, the value includes 100% of such awards, with no reduction for potential forfeiture.

    (2) These represent the amounts which potentially could have been earned under the fiscal 2024 Executive Officer Bonus Program.

    (3) These restricted stock equivalents (time-vested) awarded on November 10, 2023, will vest in three equal installments on each of the first three anniversaries of the date of grant if the officer remains employed with us at that time. The value of the amount calculated in accordance with accounting guidance is included in the “Stock Awards” column of the “Summary Compensation Table.”

    (4) These restricted stock equivalents (performance-based) awarded on November 10, 2023, will vest upon certification by the Board and release of our earnings for the fiscal year ending September 30, 2026 if the officer remains employed with us at that time and if specified performance criteria are met, subject to the exercise of negative discretion by the HC&CC. The performance criteria for these awards is relative total shareholder return for the “Performance Period” beginning on October 1, 2023 (100%). The percentage of the PRSEs vesting will range from 0% to 200% based on performance. The value of the amount calculated in accordance with accounting guidance is included in the “Stock Awards” column of the “Summary Compensation” table.

    (5) These stock options awarded on November 10, 2023 will vest in three equal installments on each of the first three anniversaries of the date of grant if the officer remains employed with us at that time. The value of the amount calculated in accordance with accounting guidance is included in the “Option Awards” column of the “Summary Compensation” table. The exercise price of $34.22 per share reflects the closing market price of our common stock on the date of grant.



    =
    OUTSTANDING EQUITY AWARDS AT FISCAL YEAR END
    The following types of equity awards have been granted to the NEOs, and remain unvested, or, in the case of non-qualified stock options, unvested or unexercised, as of September 30, 2024.
    •RSEs that vest over a period of time and at vesting convert into non-restricted shares of our common stock. As of September 30, 2024, we had outstanding unvested RSE awards with initial vesting terms of equal installments on each of the first three anniversaries of the grant date. Unvested RSE awards are included under “Stock Awards — Number of Shares or Units of Stock That Have Not Vested,” in the table below.

    •RSEs that vest subject to the achievement of performance-based conditions and at vesting convert into non-restricted shares of our common stock. As of September 30, 2024, we had outstanding unvested RSE awards with performance-based vesting conditions that will vest on a date chosen by the Board shortly after their certification once our Company releases earnings for the fiscal year ending September 30, 2024, subject to satisfaction of specific performance criteria being met. In addition, we had outstanding unvested restricted stock equivalent awards with performance-based vesting conditions that will vest on a date chosen by the Board shortly after their certification once our Company releases earnings for the fiscal year ending September 30, 2025, subject to satisfaction of specific performance criteria being met. The performance metrics are Relative Total Shareholder Return (100%). The percentage of the PRSEs vesting will range from 0% to 200% based on performance. We also had outstanding unvested restricted stock equivalent awards with performance-based vesting conditions that will vest on a date chosen by the Board shortly after their certification once our Company releases earnings for the fiscal year ending September 30, 2026, subject to satisfaction of specific performance criteria being met. The performance metrics are Relative Total Shareholder Return (100%). The percentage of the PRSEs vesting will range from 0% to 200% based on performance. Unvested awards are included under “Stock Awards — Equity Incentive Plan Awards: Number of Unearned Shares, Units or Other Rights That Have Not Vested” in the table below.

    •Non-qualified stock options granting the right to acquire shares of our common stock at an exercise price equal to the closing price of our common stock on the grant date. These options become exercisable in equal installments on each of the first three anniversaries of the grant date and remain exercisable over the ten-year period following grant. Outstanding option awards are described under “Option Awards,” in the table below.
    RSEs and non-qualified stock options were granted under the terms of our 2nd A&R 2018 Plan.
    OUTSTANDING EQUITY AWARDS AT FISCAL YEAR END TABLE
    Name
    Option Awards
    Stock Awards
    Number of
    Securities
    Underlying
    Unexercised
    Options
    (#)
    Exercisable
    Number of
    Securities
    Underlying
    Unexercised
    Options
    (#)
    Unexercisable
    Option
    Exercise
    Price
    ($)
    Option
    Expiration
    Date
    Number of
    Shares or
    Units of
    Stock That
    Have Not
    Vested
    (#)
    Market Value
    of Shares or
    Units of
    Stock That
    Have Not
    Vested
    ($) (1)
    Equity
    Incentive
    Plan
    Awards:
    Number of
    Unearned
    Shares, Units
    or Other
    Rights That
    Have Not
    Vested
    (#)
    Equity
    Incentive
    Plan
    Awards:
    Market or
    Payout Value
    of Unearned
    Shares, Units
    or Other
    Rights That
    Have Not
    Vested
    ($) (1)
    Mr. Little
    15,421
    0 (2)
    $
    42.71
    11/15/2028
    10,587 (10)
    $
    384,732
    139,756 (13)
    $
    5,078,733
    18,561
    0 (3)
    44.74
    3/1/2029
    25,157 (11)
    914,205
    166,038 (14)
    6,033,821
    96,464
    0 (4)
    31.44
    11/14/2029
    43,835 (12)
    1,592,964
    207,482 (15)
    7,539,896
    81,719
    0 (5)
    38.91
    11/13/2030
    39,050
    0 (6)
    35.37
    11/13/2030
    50,194
    25,097 (7)
    43.29
    11/12/2031
    26,282
    52,562 (8)
    39.75
    11/11/2032
    0
    89,021 (9)
    34.22
    11/10/2033
    Mr. Sullivan
    23,580
    0 (4)
    $
    31.44
    11/14/2029
    2,772 (10)
    $
    100,734
    27,721 (13)
    $
    1,007,381
    18,535
    0 (5)
    38.91
    11/13/2030
    7,044 (11)
    255,979
    35,221 (14)
    1,279,931
    8,857
    0 (6)
    35.37
    11/13/2030
    12,274 (12)
    446,037
    40,912 (15)
    1,486,742
    10,952
    5,476 (7)
    43.29
    11/12/2031
    6,133
    12,264 (8)
    39.75
    11/11/2032
    0
    20,772 (9)
    34.22
    11/10/2033
    Mr. O’Toole
    11,795
    0 (5)
    $
    38.91
    11/13/2030
    1,732 (10)
    $
    62,941
    17,326 (13)
    $
    629,627
    5,637
    0 (6)
    35.37
    11/13/2030
    5,032 (11)
    182,863
    25,158 (14)
    914,242
    6,844
    3,422 (7)
    43.29
    11/12/2031
    9,644 (12)
    350,463
    32,145 (15)
    1,168,149
    4,381
    8,760 (8)
    39.75
    11/11/2032
    0
    16,321 (9)
    34.22
    11/10/2033
    Ms. Langley
    3,354
    1,677 (16)
    $
    36.77
    4/1/2032
    3,270 (11)
    $
    118,832
    8,839 (18)
    $
    321,209
    2,848
    5,694 (8)
    39.75
    11/11/2032
    7,014 (12)
    254,889
    16,353 (14)
    594,268
    0
    11,870 (9)
    34.22
    11/10/2033
    884 (17)
    32,125
    23,379 (15)
    849,593
    Mr. Hill (19)
    17,379
    0
    $
    100.68
    7/6/2025
    14,695
    0
    74.70
    11/3/2026
    6,139
    0
    58.90
    11/13/2027
    7,711
    0
    42.71
    11/15/2028
    13,505
    0
    31.44
    1/5/2029
    10,110
    0
    38.91
    1/5/2029
    4,831
    0
    35.37
    1/5/2029
    5,933
    0
    43.29
    1/5/2029
    2,848
    0
    39.75
    1/5/2029
    Mr. Hibbert

    4,627
    0 (2)
    $
    42.71
    11/15/2028
    1,386 (10)
    $
    50,367
    13,861 (13)
    $
    503,709


    9,647


    0 (4)
    31.44
    3/1/2029
    3,270 (11)
    118,832
    16,353 (14)
    594,268


    8,425
    0 (5)
    38.91
    11/14/2029
    6,137 (12)
    377,427
    20,456 (15)
    743,371


    4,026
    0 (6)
    35.37
    11/13/2030


    5,476
    2,738 (7)
    43.29
    11/12/2031


    2,848
    5,694 (8)
    39.75
    11/11/2032


    0
    10,386 (9)
    34.22
    11/10/2033



    =
    (1) Values based on the closing price of our Company’s common stock on the NYSE on September 30, 2024, the last trading day of the fiscal year, of $36.34.

    (2) Represents stock options granted on 11/15/2018 which are fully vested and exercisable.

    (3) Represents stock options granted on 3/1/2019 which are fully vested and exercisable.

    (4) Represents stock options granted on 11/14/2019 which are fully vested and exercisable.
    (5) Represents premium stock options granted on 11/13/2020 which are fully vested and exercisable.

    (6) Represents stock options granted on 11/13/2020 which are fully vested and exercisable.

    (7) Represents stock options granted on 11/12/2021 which will vest on 11/12/2024. As of the date of this proxy, all of the options will be vested and exercisable.

    (8) Represents stock options granted on 11/11/2022 which will vest ratably on 11/11/2024 and 11/11/2025. As of the date of this proxy, two-thirds of the options will be vested and exercisable.

    (9) Represents stock options granted on 11/10/2023 which will vest ratably on 11/10/2024, 11/10/2025 and 11/10/2026. As of the date of this proxy, one-third of the options will be vested and exercisable.

    (10) Represents restricted stock equivalents granted on 11/12/2021 which will vest on 11/12/2024. As of the date of this proxy, this award will be fully vested.

    (11) Represents restricted stock equivalents granted on 11/11/2022 which will vest ratably on 11/11/2024 and 11/11/2025. As of the date of this proxy, two-thirds of this award will have vested.

    (12) Represents restricted stock equivalents granted on 11/10/2023 which will vest ratably on 11/10/2024, 11/10/2025 and 11/10/2026. As of the date of this proxy, one-third of this award will have vested.

    (13) Represents the maximum number of performance stock equivalents granted on 11/12/2021 that may vest on a date chosen by the Board shortly after their certification of our Company’s earnings for the fiscal year ending September 30, 2024 if specified performance criteria are met, subject to the exercise of negative discretion by the HC&CC. The performance metrics for this award are Relative Total Shareholder Return for the period commencing October 1, 2021 and ending on September 30, 2024. As of the date of this proxy, the final four-quarter average payout that has vested equals 99.8% of the target.

    (14) Represents the maximum number of performance stock equivalents granted on 11/11/2022 that may vest on a date chosen by the Board shortly after their certification of our Company’s earnings for the fiscal year ending September 30, 2025 if specified performance criteria are met, subject to the exercise of negative discretion by the HC&CC. The performance metrics for this award are Relative Total Shareholder Return for the period commencing October 1, 2022 and ending on September 30, 2025.

    (15) Represents the maximum number of performance stock equivalents granted on 11/10/2023 that may vest on a date chosen by the Board shortly after their certification of our Company’s earnings for the fiscal year ending September 30, 2026 if specified performance criteria are met, subject to the exercise of negative discretion by the HC&CC. The performance metrics for this award are Relative Total Shareholder Return for the period commencing October 1, 2023 and ending on September 30, 2026.

    (16) Represents stock options granted on 4/1/2022 which will vest on 4/1/2025.

    (17) Represents restricted stock equivalents granted on 4/1/2022 which will vest on 11/12/2024. As of the date of this proxy, this award will be fully vested.

    (18) Represents the maximum number of performance stock equivalents granted on 4/1/2022 that may vest on a date chosen by the Board shortly after their certification of our Company’s earnings for the fiscal year ending September 30, 2024 if specified performance criteria are met, subject to the exercise of negative discretion by the HC&CC. The performance metrics for this award are Relative Total Shareholder Return for the period commencing October 1, 2021 and ending on September 30, 2024. As of the date of this proxy, the final four-quarter average payout that has vested equals 99.8% of the target.

    (19) Due to Mr. Hill’s retirement, all of his vested stock options expire on their original expiration date or five years from his retirement date of 1/5/2024, whichever is earliest. The data in this table represents information from his Exit Form 4. The Company does not have access to updated information as he is no longer required to report to the SEC. 



    =
    OPTION EXERCISES AND STOCK VESTED
    Option Awards
    Stock Awards
    Name
    Number of Shares
    Acquired on Exercise
    (#)
    Value Realized
    on Exercise
    ($)
    Number of Shares
    Acquired on Vesting
    (#) (1)
    Value Realized
    on Vesting
    ($)
    Mr. Little
    0
    $
    0
    123,724
    $
    4,222,700 
    Mr. Sullivan
    0
    $
    0
    29,101
    $
    993,217 
    Mr. O’Toole
    0
    $
    0
    18,763
    $
    640,381 
    Ms. Langley
    0
    $
    0
    7,279
    $
    266,041 
    Mr. Hill
    0
    $
    0
    15,579
    $
    531,711 

    Mr. Hibbert





    0




    $
    0



    13,389
    $
    456,967 

    (1) In fiscal 2024, time-based RSEs and performance-based PRSEs granted to each of the officers in fiscal 2020, 2021 and 2022, vested in accordance with the terms of the awards. Upon vesting, the equivalents converted into shares of our common stock, which were then issued to the officers free of any restrictions.

    PENSION BENEFITS TABLE
    Name
    Plan Name
    Number of
    Years
    Credited
    Service
    (#)
    Present Value
    Of Accumulated
    Benefit
    ($) (1)
    Payments
    During Last
    Fiscal Year
    ($)
    Mr. Hill
    Edgewell Personal Care Company Defined Benefit Plan
    $
    273,055
    Edgewell Personal Care Company SERP
    $
    155,040
    Pension Plan for Employees of Edgewell Personal Care (2)
    1.58
    $
    35,212
    $0
    Note: Messrs. Little, Sullivan, O’Toole and Hibbert, and Ms. Langley do not participate in these plans and, as such, are not included in the table.
    (1) Based on age, benefits are available without reduction. Assumptions utilized in the valuations are set forth in “Note 14. Retirement Plans” of the Notes to Consolidated Financial Statements of our Annual Report on Form 10-K for the fiscal year ended September 30, 2024.
    (2) The amount shown for Mr. Hill reflects his participation in the Pension Plan for Employees of Edgewell Personal Care, which was a frozen plan in Canada. The plan was wound up and sold to an annuity insurance company on March 31, 2023. Amounts are converted from Canadian dollars into U.S. dollars at the exchange rate of 1 CAD equals 0.7395 USD, the exchange rate in effect as of September 30, 2024.
    NON-QUALIFIED DEFERRED COMPENSATION TABLE
    Name
    Plan
    Executive
    Contributions in
    Fiscal 2024
    ($) (1)
    Edgewell
    Contributions in
    Fiscal 2024
    ($) (2)
    Aggregate
    Earnings in
    Fiscal 2024
    ($) (3)
    Aggregate
    Withdrawals/
    Distributions
    ($)
    Aggregate
    Balance at
    9/30/2024
    ($) (4)
    Mr. Little
    ESIP
    $
    141,372
    $
    149,846
    $
    352,509
      $0
    $
    1,632,920
    Totals
    $
    141372
    $
    149,846
    $
    352,509
      $0
    $
    1,632,920
    Mr. Sullivan
    ESIP
    $
    0
    $
    0
    $
    41,880
      $0
    $
    284,880
    Totals
    $
    0
    $
    0
    $
    41,880
      $0
    $
    284,880
    Mr. O’Toole
    ESIP
    $
    65434
    $
    50,621
    $
    39,526
      $0
    $
    293,109
    Totals
    $
    65994
    $
    50,621
    $
    39,526
      $0
    $
    293,109
    Ms. Langley
    ESIP
    $
    87230
    $
    30,738
    $
    45,092
      $0
    $
    258,371
    Totals
    $
    87230
    $
    30,738
    $
    45,092
      $0
    $
    258,371
    Mr. Hill
    ESIP
    $
    30442
    $
    31,023
    $
    480,973
      $0
    $
    2,774,178
    Deferred Compensation Plan
    $
    0
    $
    0
    $
    282,254
    $
    361,392
    $
    3,296,323
    Totals
    $
    30442
    $
    31,023
    $
    763,227
    $
    361,392
    $
    6,070,501

    Mr. Hibbert
    ESIP


    $
    172355




    $
    31,069


        

    $
    236,531





    $0




    $
    1,292,338



    Totals


    $
    172355




    $
    31,069




    $
    236,531





    $0




    $
    1,292,338



    (1) Since 2012, our officers are no longer eligible to contribute to the deferred compensation plan. Mr. Hill is the only NEO who was a participant. The officer contributions to our ESIP during fiscal 2024 consist of deferrals of salary earned with respect to fiscal 2024.

    (2) Our contributions to our ESIP consist of Company contributions which would have otherwise been contributed to the 401(k) plan but for limitations imposed by the U.S. Internal Revenue Service. These amounts, in their entirety, are included in the “All Other Compensation” column of the “Summary Compensation Table.”

    (3) Aggregate earnings/(losses) shown in this column consist of:

    •amounts credited to each executive under the investment options of each of the plans, reflecting actual earnings on investment funds offered under our 401(k) plan,

    •in the case of the prime rate option of our deferred compensation plan, the actual fund return rates,

    •the appreciation or depreciation in value of each of the investment options in the plans between October 1, 2023 and September 30, 2024, and

    •the appreciation or depreciation in value of vested restricted stock equivalents (see footnote 4 below).

    The above-market portion of interest on the prime rate option (in excess of 120% of the APR) is set forth in the column titled “Change in Pension Value and Non-qualified Deferred Compensation Earnings” of the “Summary Compensation Table.”
    (4) The balances in that plan for each of the officers also include amounts deferred by them, Company matching deferrals, and earnings thereon, in years in which they were not named executive officers and their compensation was not included in the “Summary Compensation Table.” The balances also reflect earnings and losses during the past fiscal year.


    =
    POTENTIAL PAYMENTS UPON TERMINATION OR CHANGE IN CONTROL
    The value of awards which would be accelerated for our NEOs upon death, permanent disability or retirement as of September 30, 2024 is shown in the following chart. The value of accelerated restricted stock equivalents reflects a stock price of $36.34 (the closing price of our common stock on September 30, 2024, the last trading day of the fiscal year). Stock market changes since October 1, 2024 are not reflected in these valuations.

    Accelerated Restricted Stock Equivalents and
    Stock Option Awards
    Name
    Death
    Permanent
    Disability
    Retirement
    After Age 55
    With 10 years
    of Service
    Mr. Little
    $
    10,082,168
    $
    6,488,528
    $
    0
    Mr. Sullivan
    $
    2,278,249
    $
    1,554,113
    $
    0
    Mr. O’Toole
    $
    1,707,696
    $
    1,154,467
    $
    0
    Ms. Langley
    $
    1,200,913
    $
    810,706
    $
    0
    Mr. Hill
    $
    0
    $
    0
    $
    0


    Mr. Hibbert



    $
    1,106,189



    $
    75,1986



      $
    0


    Estimated Payments and Benefits
    Based on the assumptions set out above, the following sets forth estimated payments to our NEOs upon a Qualifying Termination as of September 30, 2024 under the Executive Severance Plan:

    Name
    Severance
    Salary
    Payment
    Severance
    Bonus
    Payment
    Health &
    Welfare
    Benefits
    Accrued Paid
    Time Off
    Total
    Mr. Little
    $
    2,200,000
    $
    2,750,000
    $
    73,008
    $
    0
    $
    5,023,008
    Mr. Sullivan
    $
    1,200,000
    $
    900,000
    $
    59,293
    $
    0
    $
    2,159,293
    Mr. O’Toole
    $
    975,000
    $
    731,250
    $
    50,143
    $
    0
    $
    1,756,393
    Ms. Langley
    $
    750,000
    $
    525,000
    $
    72,650
    $
    0
    $
    1,347,650


    Mr. Hibbert


    $
    725,400
    $
    507,780
    $
    54,272
    $
    0
    $
    1,287,452

    Note: Mr. Hill is not included in this table due to his retirement on January 5, 2024. Please refer to footnote 6 of the “Summary Compensation Table” for further information.
    Estimated Payments and Benefits
    Based on the assumptions set out above, the following chart sets forth estimated payments to our NEOs upon termination following a change in control. The value of accelerated restricted stock equivalents reflects a stock price of $36.34 (the closing price of our common stock on September 30, 2024, the last trading day of our fiscal year). Stock market declines and vesting and forfeitures of unvested restricted stock equivalents since October 1, 2024 are not reflected in these valuations.
    Accelerated or Additional Benefits – Termination following Change in Control
    Name
    Cash
    Severance
    Retirement
    Benefits
    Restricted
    Stock
    Equivalents,
    Three-Year
    Performance
    Awards,
    Stock Option
    Awards
    Benefits
    Excise Tax
    Reduction (1)
    Total
    Mr. Little
    $
    9,152,440
    $
    445,500
    $
    10,082,168
    $
    61,365
    $
    (378,296) 
    $
    19,363,177
    Mr. Sullivan
    $
    3,506,680
    $
    168,000
    $
    2,278,249
    $
    40,196
    $
    0
    $
    5,993,125
    Mr. O’Toole
    $
    2,840,344
    $
    136,500
    $
    1,707,696
    $
    29,418
    $
    0
    $
    4,713,958
    Ms. Langley
    $
    2,075,640
    $
    125,820
    $
    1,177,093
    $
    40,215
    $
    (460,613)
    $
    2,958,155


    Mr. Hibbert




    $
    2,023,963





    $
    98,654





    $
    1,106,189





    $
    40,910





    $
    0





    $
    3,269,716



    (1) It was determined that a “golden parachute” excise tax would be due under the Code for Mr. Little and Ms. Langley and, therefore, we reduced the aggregate amount of the payments that would be payable to an amount such that no excise tax would be due.
    Note: Mr. Hill is not included in this table due to his retirement on January 5, 2024.




    =
    PAY VERSUS PERFORMANCE
    As required by Section 953(a) of the Dodd-Frank Act, and Item 402(v) of Regulation S-K, we are providing the following information about the relationship between executive “compensation actually paid” and certain company financial performance metrics. Compensation actually paid, as determined under SEC requirements, does not reflect the actual amount of compensation earned by or paid to our executive officers during a covered year. For further information concerning our pay-for-performance philosophy and how we align executive compensation with company financial performance, refer to the Compensation Discussion and Analysis.
    Information presented in this section will not be deemed to be incorporated by reference into any of our filings under the Securities Act of 1933, as amended, or the Exchange Act, except as we may specifically do so.
    Year (2)
    Pay
    Performance
    CEO
    Average of Other NEOs
    Cumulative Total Shareholder
    Return (Value of  $100 Initial
    Investment) (1):
    Net
    Income
    ($Mn)
    Adjusted
    EBITDA (6)
    ($Mn)
    SCT Total
    Compensation
    Compensation
    Actually Paid (3)
    SCT Total
    Compensation
    Compensation
    Actually Paid (4)
    EPC
    Peer Group (5)
    2024
    $
    10,078,914
    $
    6,817,054
    $
    2,310,918
    $
    1,714,919
    $
    138.78
    $
    132.51
    $
    98.6
    $
    353
    2023
    $
    10,517,129
    $
    9,124,943
    $
    2,310,328
    $
    1,872,883
    $
    138.92
    $
    106.10
    $
    114.7
    $
    342
    2022
    $
    9,320,280
    $
    10,600,848
    $
    1,900,947
    $
    2,402,210
    $
    138.52
    $
    91.47
    $
    99.5
    $
    335
    2021
    $
    8,104,026
    $
    11,957,823
    $
    2,158,258
    $
    2,615,423
    $
    132.34
    $
    100.05
    $
    117.8
    $
    367
    (1) Represents the value of a hypothetical $100 investment beginning at market close on September 29, 2021, assuming reinvestment of dividends

    (2) The CEO for each covered year was Rod R. Little. The other NEOs for each covered year were as follows:

    •2024: Daniel J. Sullivan, Eric F. O’Toole, LaTanya Langley, John N. Hill and Paul R. Hibbert

    •2023: Daniel J. Sullivan, Eric F. O’Toole, John N. Hill and Paul R. Hibbert

    •2022: Daniel J. Sullivan, Eric F. O’Toole, John N. Hill and Paul R. Hibbert

    •2021: Daniel J. Sullivan, Eric F. O’Toole, Marisa B. Iasenza and Anne-Sophie Gaget
    (3) Amounts reported in this column are based on total compensation reported for our CEO in the Summary Compensation Table for the indicated fiscal years and adjusted as shown in the table below. Fair value of equity awards was computed in accordance with the Company’s methodology used for financial reporting purposes.

    2024
    Total Compensation for CEO as reported SCT for the covered year
    $
    10,078,914
    Deduct pension values reported in SCT for the covered year
    $
    0
    Deduct grant date fair value of equity awards reported in SCT for the covered year
    $
    (7,467,973)
    Add pension value attributable to current year’s service and any change in pension value attributable to plan amendments made in the covered year
    $
    0
    Add fair values as of the end of the covered year of all equity awards granted during the covered year
    that are outstanding and unvested as of the end of such covered year
    $
    6,994,477
    Add fair value as of the vesting date of any awards granted in the covered year that vested during the
    covered year
    $
    0
    Add dividends paid on unvested shares/share units and stock options
    $
    201,256
    Add the change in fair value (whether positive or negative) as of the end of the covered year of any equity awards granted in any prior year that are outstanding and unvested as of the end of such covered year
    $
    (2,377,963)
    Add the change in fair value (whether positive or negative) as of the vesting date of any equity awards
    granted in any prior year for which all applicable vesting conditions were satisfied during the covered
    year
    $
    (611,657)
    Subtract the fair value of any equity awards granted in a prior year that were forfeited in the covered
    year determined as of the end of the prior year
    $
    0
    Compensation Actually Paid to CEO
    $
    6,817,054
    (4) Amounts reported in this column are based on average total compensation reported for our Other NEOs in the Summary Compensation Table for the indicated fiscal years and adjusted as shown in the table below. Fair value of equity awards was computed in accordance with the Company’s methodology used for financial reporting purposes.

    2024
    Average Total Compensation for Other NEOs as reported SCT for the covered year
    $
    2,310,918
    Deduct average pension values reported in SCT for the covered year
    $
    (47,766)
    Deduct average grant date fair value of equity awards reported in SCT for the covered year
    $
    (937,262)
    Add average pension value attributable to current year’s service and any change in pension value attributable to plan amendments made in the covered year
    $
    0
    Add average fair values as of the end of the covered year of all equity awards granted during the covered year that are outstanding and unvested as of the end of such covered year
    $
    888,307
    Add average fair value as of the vesting date of any awards granted in the covered year that vested during the covered year
    $
    0
    Add average dividends paid on unvested shares/share units and stock options
    $
    31,071
    Add the average change in fair value (whether positive or negative) as of the end of the covered year of
    any equity awards granted in any prior year that are outstanding and unvested as of the end of such
    covered year
    $
    (255,459)
    Add the average change in fair value (whether positive or negative) as of the vesting date of any equity
    awards granted in any prior year for which all applicable vesting conditions were satisfied during the
    covered year
    $
    (65,737)


    =
    Subtract the average fair value of any equity awards granted in a prior year that were forfeited in the covered year determined as of the end of the prior year
    $
    (209,153)
    Average Compensation Actually Paid to Other NEOs
    $
    1,714,919
    (5) Pursuant to Item 402(v) of Regulation S-K, the Company used the same peer group used for purposes of Item 201(e) of Regulation S-K, the S&P Composite 1500 Household Products Index.

    (6) Represent Adjusted EBITDA as shown in Appendix A.
    Company’s Most Important Financial Performance Measures
    The following were the most important financial performance measures used by the company to link executive compensation actually paid to the company’s NEOs for the most recently completed fiscal year to the company’s performance:
    ► Total Shareholder Return (“TSR”)
    ► Adjusted EBITDA
    ►Net Income
    Description of the Relationship Between Compensation Actually Paid to our Named Executive Officers and Company Performance
    The charts below describe the relationship between compensation actually paid to our chief executive officer and to our other named executive officers (as calculated above) and our financial and stock performance for the indicated years. In addition, the first chart below compares our cumulative TSR and peer group cumulative TSR for the indicated years.
    image_2.jpg
    image_3.jpg



    =
    image_4.jpg


     



    =
    STOCK OWNERSHIP INFORMATION
    (updates)
    OWNERSHIP BY DIRECTORS AND EXECUTIVE OFFICERS
    The table below contains information regarding beneficial common stock ownership by our directors, NEOs, and directors and executive officers as a group as of November 29, 2024. It does not reflect any changes in ownership that may have occurred after that date. In general, “beneficial ownership” includes those shares a director or executive officer has the power to vote or transfer, as well as shares owned by immediate family members that reside with the director or officer. Unless otherwise indicated, directors and executive officers named in the table below have sole voting and investment power with respect to the shares set forth in the table and none of the stock included in the table is pledged. The table also indicates shares that may be obtained within 60 days upon the exercise of options, or upon the conversion of unvested RSEs into shares of common stock.
    Directors and
    Executive Officers
    Shares
    Beneficially
    Owned
    % of Shares
    Outstanding (1)
    (*denotes less
    than 1%)
    Robert W. Black (2)
    20,112
    *
    George R. Corbin (3)
    20,112
    *
    Carla C. Hendra (4)
    14,648
    *
    John C. Hunter, III (5)
    47,181
    *
    James C. Johnson (6)
    28,404
    *
    Joseph D. O’Leary (7)
    20,432
    *
    Rakesh Sachdev (8)
    24,323
    *
    Swan Sit (9)
    15,499
    *
    Stephanie Stahl (10)
    0
    *
    Gary K. Waring (11)
    20,432
    *
    Rod R. Little (12)
    719,256
    1.5%
    Daniel J. Sullivan (13)
    177,007
    *
    Eric F. O’Toole (14)
    74,292
    *
    LaTanya Langley (15)
    25,925
    *
    John N. Hill (16)
    164,231
    *


    Paul R. Hibbert (17)





    87,392






    *



    All Executive Officers and Directors as a Group (18 persons)
    1,459,246
    3.0%
    (1) The number of shares outstanding for purposes of this calculation was the number outstanding as of November 29, 2024 plus the number of shares which could be acquired upon the exercise of vested options, or options that vest within 60 days of that date, by the applicable officer or director, the conversion of unvested RSEs as well as equivalents that vest within 60 days of that date and the number of stock equivalents held in the deferred compensation plan.

    (2) For Mr. Black: includes (i) 16,168 shares owned by Mr. Black; and (ii) 3,944 vested RSEs deferred until retirement from our Board. Does not include 3,853 unvested RSEs that will convert into shares of our common stock on February 5, 2025.

    (3) For Mr. Corbin: includes (i) 13,419 shares owned by Mr. Corbin; and (ii) 6,693 vested RSEs deferred until retirement from our Board. Does not include 3,853 unvested RSEs which will be deferred when they vest on February 5, 2025.

    (4) For Ms. Hendra: includes (i) 7,917 shares owned by Ms. Hendra; and (ii) 6,731 vested RSEs deferred until retirement from our Board. Does not include 3,853 unvested RSEs which will be deferred when they vest on February 5, 2025.

    (5) For Mr. Hunter: includes (i) 6,603 shares owned by Mr. Hunter; (ii) 22,709 vested RSEs deferred until retirement from our Board; and (iii) 17,869 units held in the Deferred Compensation Plan. Does not include 3,853 unvested RSEs which will be deferred when they vest on February 5, 2025.

    (6) For Mr. Johnson: includes (i) 2,000 shares owned by Mr. Johnson; (ii) 26,225 vested RSEs deferred until retirement from our Board; and (iii) 179 units held in the Deferred Compensation Plan. Does not include 3,853 unvested RSEs which will be deferred when they vest on February 5, 2025.
    (7) For Mr. O’Leary: includes (i) 17,276 shares owned by Mr. O’Leary; and (ii) 3,156 vested RSEs deferred until retirement from our Board. Does not include 3,853 unvested RSEs that will convert into shares of our common stock on February 5, 2025.

    (8) For Mr. Sachdev: includes 24,323 vested RSEs deferred until retirement from our Board. Does not include 3,853 unvested RSEs which will be deferred when they vest on February 5, 2025.

    (9) For Ms. Sit: includes 15,499 shares owned by Ms. Sit. Does not include 3,853 unvested RSEs which will be deferred when they vest on February 5, 2025.

    (10) For Ms. Stahl: has 2,773 and 1,340 unvested RSE awards which will be deferred when they vest on September 10, 2027 and February 5, 2025, respectively.

    (11) For Mr. Waring: includes (i) 2,677 shares owned by Mr. Waring; and (ii) 17,755 vested RSEs deferred until retirement from our Board. Does not include 3,853 unvested RSEs of which 60% will be deferred and 40% will convert into shares of our common stock when they vest on February 5, 2025.

    (12) For Mr. Little: includes (i) 310,513 shares owned by Mr. Little; and (ii) 408,743 vested but unexercised stock options. Does not include 93,654 unvested RSEs; 615,501 unvested PRSEs or 85,628 unvested stock options.

    (13) For Mr. Sullivan: includes (i) 90,418 shares owned by Mr. Sullivan; and (ii) 86,589 vested but unexercised stock options. Does not include 29,404 unvested RSEs; 129,231 unvested PRSEs; or 19,880 unvested stock options.



    =
    (14) For Mr. O’Toole: includes (i) 32,391 shares owned by Mr. O’Toole; and (ii) 41,901 vested but unexercised stock options which he has 90 days from his departure on 11/15/2024 to exercise. Due to Mr. O’Toole’s departure, his unvested awards were forfeited.

    (15) For Ms. Langley: includes (i) 12,919 shares owned by Ms. Langley; and (ii) 13,006 vested but unexercised stock options. Does not include 17,373 unvested RSEs; 56,325 unvested PRSEs; or 12,437 unvested stock options.

    (16) For Mr. Hill: includes at the time of his retirement (i) 81,080 shares owned by Mr. Hill; and (ii) 83,151 vested stock options. Due to Mr. Hill’s retirement, all of his vested stock options expire on their original expiration date or five years from his retirement date of 1/5/2024, whichever is earliest. The data in this table represents information from his Exit Form 4. The Company does not have access to updated information as he is no longer required to report to the SEC.

    (17) For Mr. Hibbert: includes (i) 43,296 shares owned by Mr. Hibbert; and (ii) 44,096 vested but unexercised stock options. Does not include 19,001 unvested RSEs; 56,721 unvested PRSEs; or 9,771 unvested stock options.

    Get the next $EPC alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $EPC

    DatePrice TargetRatingAnalyst
    2/8/2024$39.00Underweight → Equal Weight
    Barclays
    4/5/2023$47.00Neutral
    UBS
    11/17/2022$48.00Buy
    Canaccord Genuity
    10/26/2022$47.00 → $42.00Buy → Neutral
    Goldman
    10/17/2022$40.00 → $36.00Equal-Weight → Underweight
    Morgan Stanley
    2/10/2022$46.00 → $43.00Equal-Weight
    Morgan Stanley
    2/9/2022$55.00 → $47.00Overweight
    Wells Fargo
    1/5/2022$41.00 → $55.00Underweight → Overweight
    Wells Fargo
    More analyst ratings

    $EPC
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Hawaiian Tropic Embarks on Bold New Chapter with Launch of "Tana Sutra" Campaign Featuring Alix Earle

      The brand's new Tana Sutra guide marks the return of Hot Girl Summer, one playfully provocative position at a time. SHELTON, Conn., May 15, 2025 /PRNewswire/ -- Hawaiian Tropic, renowned for its signature scent and iconic suncare products, announces the launch of its boldest campaign yet: Tana Sutra, a tongue-in-cheek guide of tan-tric positions to achieve the optimal glow. Featuring social media mega star and it-girl Alix Earle, the campaign empowers people to let their flirtiest, most confident selves shine all summer long.   "This is a breakthrough moment for Hawaiian Tropic. 'Tana Sutra' is the largest creative campaign in the history of the brand," said Veron

      5/15/25 10:00:00 AM ET
      $EPC
      Package Goods/Cosmetics
      Consumer Discretionary
    • Edgewell Personal Care Announces Second Quarter Fiscal 2025 Results

      Net Sales decreased 3.1%, Organic Net Sales decreased 1.5% Gross Margin increased 100-basis pointsGAAP EPS decreased $0.12, Adjusted EPS decreased $0.01Updates Full Year Outlook SHELTON, Conn., May 7, 2025 /PRNewswire/ -- Edgewell Personal Care Company (NYSE:EPC) today announced results for its second fiscal quarter 2025 ended March 31, 2025.  Executive Summary Net sales were $580.7 million, a decrease of 3.1% compared to the prior year quarter.Organic net sales decreased 1.5% (Organic basis excludes the impact from currency movements.)GAAP Diluted Net Earnings Per Share ("EP

      5/7/25 6:00:00 AM ET
      $EPC
      Package Goods/Cosmetics
      Consumer Discretionary
    • Edgewell Personal Care Company to Webcast a Discussion of Second Quarter Fiscal Year 2025 Results on May 7, 2025

      SHELTON, Conn., April 14, 2025 /PRNewswire/ -- Edgewell Personal Care Company (NYSE:EPC) will report its financial results for the second quarter fiscal year 2025 before the market opens on May 7, 2025. Edgewell will discuss its results during an investor conference call that will be webcast on May 7, 2025, beginning at 8:00 a.m. Eastern Time. The call will be hosted by President and Chief Executive Officer Rod Little, Chief Operating Officer Dan Sullivan, and Chief Financial Officer Francesca Weissman. All interested parties may access a live webcast of this conference call a

      4/14/25 10:57:00 AM ET
      $EPC
      Package Goods/Cosmetics
      Consumer Discretionary

    $EPC
    SEC Filings

    See more
    • SEC Form SCHEDULE 13G filed by Edgewell Personal Care Company

      SCHEDULE 13G - EDGEWELL PERSONAL CARE Co (0001096752) (Subject)

      5/14/25 1:43:18 PM ET
      $EPC
      Package Goods/Cosmetics
      Consumer Discretionary
    • SEC Form 144 filed by Edgewell Personal Care Company

      144 - EDGEWELL PERSONAL CARE Co (0001096752) (Subject)

      5/13/25 7:17:48 PM ET
      $EPC
      Package Goods/Cosmetics
      Consumer Discretionary
    • SEC Form 10-Q filed by Edgewell Personal Care Company

      10-Q - EDGEWELL PERSONAL CARE Co (0001096752) (Filer)

      5/7/25 4:29:26 PM ET
      $EPC
      Package Goods/Cosmetics
      Consumer Discretionary

    $EPC
    Leadership Updates

    Live Leadership Updates

    See more
    • Edgewell Personal Care Appoints Jessica Spence as President of North America Business

      SHELTON, Conn., Oct. 2, 2024 /PRNewswire/ -- Edgewell Personal Care Company (NYSE: EPC) is pleased to announce the appointment of Jessica Spence as President of its North America business, effective October 24, 2024. In this role, Spence will lead Edgewell's North American commercial business and will report directly to Rod Little, President and Chief Executive Officer. Edgewell's President and Chief Executive Officer, Rod Little commented, "We are thrilled to welcome Jessica to our team. Jessica is a seasoned and accomplished leader with an impressive brand-building and opera

      10/2/24 10:27:00 AM ET
      $EPC
      Package Goods/Cosmetics
      Consumer Discretionary
    • Edgewell Personal Care Appoints Stephanie Stahl to Board of Directors

      SHELTON, Conn., Sept. 12, 2024 /PRNewswire/ -- Edgewell Personal Care Company (NYSE: EPC) announced that it has appointed Stephanie Stahl to its Board of Directors, effective September 10. Following her appointment, the Board will now include 11 members. As a consumer-driven and sustainability-focused business leader, brand builder, board member and advisor, Stahl has extensive marketing and strategy experience in high-growth, turnaround and early-stage operating environments. She also has significant business transformation, post-merger integration and public board leadership

      9/12/24 1:08:00 PM ET
      $EPC
      Package Goods/Cosmetics
      Consumer Discretionary
    • Edgewell Personal Care Announces Appointment of John Dunham as Chief Accounting Officer

      SHELTON, Conn., Feb. 23, 2024 /PRNewswire/ -- Edgewell Personal Care Company (NYSE:EPC) today announced the appointment of John Dunham as Chief Accounting Officer (CAO). Mr. Dunham will be based in the Company's Shelton, Connecticut office reporting to Dan Sullivan, Chief Financial Officer. "John is a seasoned accounting executive with over twenty years of broad-based technical and operational accounting experience. During his career, he has demonstrated a track record of success in improving operational accounting effectiveness and regulatory compliance as well as developing

      2/23/24 8:30:00 AM ET
      $EPC
      Package Goods/Cosmetics
      Consumer Discretionary

    $EPC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Edgewell Personal Care upgraded by Barclays with a new price target

      Barclays upgraded Edgewell Personal Care from Underweight to Equal Weight and set a new price target of $39.00

      2/8/24 6:30:53 AM ET
      $EPC
      Package Goods/Cosmetics
      Consumer Discretionary
    • UBS initiated coverage on Edgewell Personal Care with a new price target

      UBS initiated coverage of Edgewell Personal Care with a rating of Neutral and set a new price target of $47.00

      4/5/23 8:58:06 AM ET
      $EPC
      Package Goods/Cosmetics
      Consumer Discretionary
    • Canaccord Genuity initiated coverage on Edgewell Personal Care with a new price target

      Canaccord Genuity initiated coverage of Edgewell Personal Care with a rating of Buy and set a new price target of $48.00

      11/17/22 7:20:11 AM ET
      $EPC
      Package Goods/Cosmetics
      Consumer Discretionary

    $EPC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Edgewell Personal Care Company

      SC 13G/A - EDGEWELL PERSONAL CARE Co (0001096752) (Subject)

      11/8/24 10:55:54 AM ET
      $EPC
      Package Goods/Cosmetics
      Consumer Discretionary
    • SEC Form SC 13G/A filed by Edgewell Personal Care Company (Amendment)

      SC 13G/A - EDGEWELL PERSONAL CARE Co (0001096752) (Subject)

      2/13/24 5:04:49 PM ET
      $EPC
      Package Goods/Cosmetics
      Consumer Discretionary
    • SEC Form SC 13G/A filed by Edgewell Personal Care Company (Amendment)

      SC 13G/A - EDGEWELL PERSONAL CARE Co (0001096752) (Subject)

      2/12/24 11:09:25 AM ET
      $EPC
      Package Goods/Cosmetics
      Consumer Discretionary

    $EPC
    Financials

    Live finance-specific insights

    See more
    • Edgewell Personal Care Announces Second Quarter Fiscal 2025 Results

      Net Sales decreased 3.1%, Organic Net Sales decreased 1.5% Gross Margin increased 100-basis pointsGAAP EPS decreased $0.12, Adjusted EPS decreased $0.01Updates Full Year Outlook SHELTON, Conn., May 7, 2025 /PRNewswire/ -- Edgewell Personal Care Company (NYSE:EPC) today announced results for its second fiscal quarter 2025 ended March 31, 2025.  Executive Summary Net sales were $580.7 million, a decrease of 3.1% compared to the prior year quarter.Organic net sales decreased 1.5% (Organic basis excludes the impact from currency movements.)GAAP Diluted Net Earnings Per Share ("EP

      5/7/25 6:00:00 AM ET
      $EPC
      Package Goods/Cosmetics
      Consumer Discretionary
    • Edgewell Personal Care Company to Webcast a Discussion of Second Quarter Fiscal Year 2025 Results on May 7, 2025

      SHELTON, Conn., April 14, 2025 /PRNewswire/ -- Edgewell Personal Care Company (NYSE:EPC) will report its financial results for the second quarter fiscal year 2025 before the market opens on May 7, 2025. Edgewell will discuss its results during an investor conference call that will be webcast on May 7, 2025, beginning at 8:00 a.m. Eastern Time. The call will be hosted by President and Chief Executive Officer Rod Little, Chief Operating Officer Dan Sullivan, and Chief Financial Officer Francesca Weissman. All interested parties may access a live webcast of this conference call a

      4/14/25 10:57:00 AM ET
      $EPC
      Package Goods/Cosmetics
      Consumer Discretionary
    • Edgewell Personal Care Announces First Quarter Fiscal 2025 Results

      Net Sales decreased 2.1%, Organic Net Sales decreased 1.3% GAAP EPS decreased $0.13, Adjusted EPS decreased $0.17, or flat at constant currencyUpdates Full Year Outlook to reflect Foreign Currency Changes SHELTON, Conn., Feb. 10, 2025 /PRNewswire/ -- Edgewell Personal Care Company (NYSE:EPC) today announced results for its first fiscal quarter 2025 ended December 31, 2024.  Executive Summary Net sales were $478.4 million, a decrease of 2.1% compared to the prior year quarter.Organic net sales decreased 1.3% (Organic basis excludes the impact from currency movements.)GAAP Dilu

      2/10/25 6:00:00 AM ET
      $EPC
      Package Goods/Cosmetics
      Consumer Discretionary

    $EPC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4 filed by Director Sit Swan

      4 - EDGEWELL PERSONAL CARE Co (0001096752) (Issuer)

      2/10/25 9:58:55 AM ET
      $EPC
      Package Goods/Cosmetics
      Consumer Discretionary
    • SEC Form 4 filed by Director Hendra Carla C

      4 - EDGEWELL PERSONAL CARE Co (0001096752) (Issuer)

      2/10/25 9:54:46 AM ET
      $EPC
      Package Goods/Cosmetics
      Consumer Discretionary
    • SEC Form 4 filed by Director Waring Gary

      4 - EDGEWELL PERSONAL CARE Co (0001096752) (Issuer)

      2/10/25 9:52:14 AM ET
      $EPC
      Package Goods/Cosmetics
      Consumer Discretionary